- Home
- SNDX vs BOW Comparison
SNDX vs BOW Comparison
Compare SNDX & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- BOW
- Stock Information
- Founded
- SNDX 2005
- BOW 2020
- Country
- SNDX United States
- BOW United States
- Employees
- SNDX N/A
- BOW N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- BOW Property-Casualty Insurers
- Sector
- SNDX Health Care
- BOW Finance
- Exchange
- SNDX Nasdaq
- BOW Nasdaq
- Market Cap
- SNDX 1.2B
- BOW 1.1B
- IPO Year
- SNDX 2016
- BOW 2024
- Fundamental
- Price
- SNDX $14.34
- BOW $32.97
- Analyst Decision
- SNDX Strong Buy
- BOW Hold
- Analyst Count
- SNDX 10
- BOW 5
- Target Price
- SNDX $36.20
- BOW $33.60
- AVG Volume (30 Days)
- SNDX 2.1M
- BOW 95.3K
- Earning Date
- SNDX 02-25-2025
- BOW 02-15-2025
- Dividend Yield
- SNDX N/A
- BOW N/A
- EPS Growth
- SNDX N/A
- BOW 130.44
- EPS
- SNDX N/A
- BOW 1.08
- Revenue
- SNDX $16,000,000.00
- BOW $389,135,000.00
- Revenue This Year
- SNDX N/A
- BOW N/A
- Revenue Next Year
- SNDX N/A
- BOW $26.70
- P/E Ratio
- SNDX N/A
- BOW $30.70
- Revenue Growth
- SNDX N/A
- BOW 107.43
- 52 Week Low
- SNDX $12.06
- BOW $22.14
- 52 Week High
- SNDX $25.34
- BOW $37.81
- Technical
- Relative Strength Index (RSI)
- SNDX 54.69
- BOW N/A
- Support Level
- SNDX $13.97
- BOW N/A
- Resistance Level
- SNDX $13.16
- BOW N/A
- Average True Range (ATR)
- SNDX 0.66
- BOW 0.00
- MACD
- SNDX 0.17
- BOW 0.00
- Stochastic Oscillator
- SNDX 85.39
- BOW 0.00
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc is engaged in providing specialty P&C products. It is a specialty insurance group that generates revenues by underwriting and offering a variety of specialty insurance products to domestic markets through three distinct underwriting divisions: Casualty, Professional Liability and Healthcare. Casualty specialize in GL coverage for risks in the construction, distribution, heavy manufacturing, real estate and hospitality segments and also consider underwriting risks in a broader range of industries. Key revenue is generated from Casualty segment.